Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton, Faculty of Medicine, School of Cancer Sciences

The Antibody and Vaccine Group based in the Centre for Cancer Immunology in Southampton has a strong track-record in basic and translational immunology. One of its central aims is to develop new and more effective antibody reagents for treating cancer.

An exciting opportunity now presents itself for a research fellow to work on a NIH-funded project to determine how specialized immune cells called macrophages recognize and destroy target cells tagged by antibodies and to understand why they sometimes do not. In collaboration with Dr Adam Hoppe at South Dakota University, USA, the post-holder will leverage expertise in antibody biology, macrophages and CRISPR screening in order to gain new understanding of this critical antibody effector mechanism with the aim of improving cancer treatments.

You will be motivated, educated to PhD level in a relevant subject area and ideally have practical laboratory experience of antibody biology, myeloid cells, bioinformatics and in vivo methodology.

The position is full-time and for 7 months. Informal queries should be directed to Professor Mark Cragg (msc@soton.ac.uk)

Details about the School of Cancer Sciences and Centre for Cancer Immunology can be found at https://www.southampton.ac.uk/about/faculties-schools-departments/school-of-cancer-sciences  and https://www.southampton.ac.uk/research/institutes-centres/centre-for-cancer-immunology